The ASAM Pain & Addiction: Common Threads Course XVIII 2017 (7.5 CME)

The theme for the 18th year of The ASAM Pain & Addiction: Common Threads Course is There and Back Again. In the past couple years, research and clinical guidelines for treating patients with pain and/or addiction have evolved dramatically, challenging the traditional way providers think about pain and addiction. Experts in the field will review the scientific, legislative, and clinical updates from the recent months and examine how these updates will affect the methods providers use to treat their patients. Presenters will also address how the “traditional” pain and addiction provider has changed and how to get providers from diverse backgrounds on the same page for patient care. Participants will learn about the many paradigm-shifting updates to the field through a series of mini-lectures. Participants will discuss ways to apply these changes to their practices with a rousing afternoon discussion with peers. Course attendees will leave the course with new knowledge and an understanding that can be immediately applied to their clinical practice.

  • Evaluation and Certificate - Pain & Addiction 2017

    Contains 2 Component(s), Medical Credits Offered

    CME Evaluation for The ASAM Pain & Addiction: Common Threads XVIII 2017.

    CME Evaluation for The ASAM Pain & Addiction: Common Threads XVIII 2017. Complete the course evaluation first and then claim credits. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

  • Pain, Addiction, and Opioids - There and Back Again: Lecturettes (4.5 CME)

    Contains 13 Component(s), Medical Credits Offered

    Experts in the field will review the scientific, legislative, and clinical updates from the recent months and examine how these updates will affect the methods providers use to treat their patients. Presenters will also address how the “traditional” pain and addiction provider has changed and how to get providers from diverse backgrounds on the same page for patient care. Participants will learn about the many paradigm-shifting updates to the field through a series of mini-lectures.

    Experts in the field will review the scientific, legislative, and clinical updates from the recent months and examine how these updates will affect the methods providers use to treat their patients. Presenters will also address how the “traditional” pain and addiction provider has changed and how to get providers from diverse backgrounds on the same page for patient care. Participants will learn about the many paradigm-shifting updates to the field through a series of mini-lectures.

    Michael Sprintz

    DO, DFASAM

    Michael Sprintz, D.O. received his medical degree from Midwestern University-Chicago College of Osteopathic Medicine in 1997 and went on to a residency in Anesthesiology at Johns Hopkins Hospital. He left Hopkins to do post-doctoral research in biomedical nanotechnology before returning to complete his anesthesia training at University of South Florida. Dr. Sprintz completed a Pain Medicine Fellowship at MD Anderson Cancer Center in 2012 and is triple-board-certified in Anesthesiology, Addiction Medicine, and Pain Medicine. Dr. Sprintz is the Past-President of the Texas Society of Addiction Medicine, as well as the CEO of iLumHealth, a software company developing world-class products to prevent abuse and diversion of prescription drugs, educate providers, and employ rational solutions that save lives and create value. In addition, Dr. Sprintz is the Founder and Chief Medical Officer of the Sprintz Center for Pain and Dependency, an ultra-specialized outpatient center for the comprehensive treatment of chronic pain, dependency and addiction, located in The Woodlands, TX.

    Andrea G. Barthwell

    MD, DFASAM

    Andrea Grubb Barthwell, M.D., F.A.S.A.M., is the founder and Chief Executive Officer of the global health care and policy-consulting firm EMGlobal LLC and Director at Two Dreams Outer Banks Treatment Center. President George W. Bush nominated Dr. Barthwell in December 2001 to serve as Deputy Director for Demand Reduction in the Office of National Drug Control Policy (ONDCP). The United States Senate confirmed her nomination on January 28, 2002. As a member of the President's sub-cabinet, Dr. Barthwell was a principal advisor in the Executive Office of the President (EOP) on policies aimed at reducing the demand for illicit drugs. Dr. Barthwell received a Bachelor of Arts degree in Psychology from Wesleyan University, where she serves on the Board of Trustees, and a Doctor of Medicine from the University of Michigan Medical School. Following post-graduate training at the University of Chicago and Northwestern University Medical Center, she began her practice in the Chicago area. Dr. Barthwell served as President of the Encounter Medical Group (EMG, an affiliate of EMGlobal), was a founding member of the Chicago Area AIDS Task Force, hosted a weekly local cable show on AIDS, and is a past president of the American Society of Addiction Medicine. In 2003, Dr. Barthwell received the Betty Ford Award, given by the Association for Medical Education and Research in Substance Abuse. In 1997, Dr. Barthwell's peers named her one of the "Best Doctors in America" in addiction medicine.

    Alexander Y. Walley

    MD, MSc, FASAM

    Alexander Y. Walley, M.D., M.Sc., is an Associate Professor of Medicine at Boston University School of Medicine, a general internist and addiction medicine specialist at Boston Medical Center. He is the director of the Addiction Medicine Fellowship program and founded the Inpatient Addiction Consult Service at Boston Medical Center. He does clinical and research-related work on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based buprenorphine treatment for HIV patients and methadone maintenance treatment. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. 

    William Jacobs

    MD

    William S. Jacobs, M.D, Associate Professor, Medical College of Georgia. is a national clinical expert, triple board certified in Anesthesiology, Pain Medicine, and Addiction Medicine physician. A Magna Cum Laude University of Georgia undergraduate and graduate of the Medical College of Georgia, Dr. Jacobs did his Anesthesiology Residency at the University of Alabama-Birmingham. He had a 13 year career as a private practitioner in anesthesiology and pain management before matriculating to UF for his Addiction Medicine Fellowship.

    Dr. Jacobs has been a national expert, testifying on Capitol Hill on MDMA and prescription misuse and abuse. He was a medical and scientific Consultant to the US Senate as well as the Department of Labor. Dr Jacobs has also testified and consulted for the DEA on safe prescribing of narcotic drugs and the model of ideal treatment programs. Dr. Jacobs has been the Medical Director of non-profit, profit, and academic chemical dependency and dual diagnosis programs. After his promotion to Associate Professor, he left academia and started NexStep Integrated Pain Care Inc., a model outpatient program for the treatment of patients with both chronic pain and addiction disorders. He returned to the University of Florida full time as Associate Professor in Psychiatry and Addiction Medicine: Co-Chief of Pain Medicine in 2012.

    Dr. Jacobs is the author of peer reviewed scientific papers, abstracts, textbook chapters including the ASAM and APA definitive substance use volumes, and practice guidelines including highly cited studies on mitigating opioid abuse in chronic pain treatment, physician recovery, naltrexone, urine drug testing, and body mass index and alcohol use.

    Dr Jacobs has returned home to Georgia to become the first Chief of Addiction Medicine at The Medical College of Georgia He is also Medical Director of The Bluff Plantation as well as Chief Medical Officer for Georgia Detox & Recovery.

    Mark Pew

    Mark Pew, Senior Vice President of PRIUM, has more than 35 years of experience in the property and casualty, healthcare and technology industries.  He created PRIUM’s Medical Intervention Program in 2003, Intervention Triage in 2010, Texas Drug Formulary turnkey solution in 2011, Centers with Standards in 2012, and TaperRx in 2014.

    Mark is a popular speaker at workers’ compensation conferences around the country as well as individual continuing education venues.  He has spoken at the National Workers’ Compensation and Disability Conference, National Rx Drug Abuse & Heroin Summit, and 56 other national or statewide gatherings around the country. From March 2012 thru January 2017, Mark presented educational content 392 times to 26,873 people in 40 states + DC, including 16 national webinars.
    A frequent media source for stories on pharmacy, chronic pain and marijuana in workers’ compensation, Mark is a regular article contributor to Claim Management Magazine, Workers’ Compensation Magazine, Insurance Thought Leader and LexisNexus. He also publishes thought-provoking original-content on LinkedIn and @RxProfessor.
    Mark was named one of the “Best Blogs of 2016” by WorkersCompensation.com and received the prestigious Magna Comp Laude award at WorkCompCentral’s 2016 Comp Laude Awards Gala.
    Mark serves on the Medical Issues Committee of the International Association of Industrial Accident Boards and Commissions (IAIABC), the Workers’ Compensation Committee for the Self-Insurance Institute of America (SIIA), and the Pharmacy Group for CompSense in California (chairman) and New York. In addition, he serves as a technical advisor to multiple jurisdictions on subjects such as drug formularies, treatment guidelines and medicinal use of cannabis.
    To know more about who Mark is and why he does what he does, read “Thursday Thought Leaders” at http://www.legalnetinc.com/2017/02/09/thursday-thought-leader-mark-pew/.

    R. Corey Waller

    MD, MS, DFASAM

    R. Corey Waller, MD, MS, FACEP, DFASAM, is an addiction, pain and emergency medicine specialist. Dr. Waller earned his bachelor's degree in biology and his master's degree in neuromolecular biology at Southwest Texas State University in San Marcos, Texas. He earned his medical degree at University of Texas Medical School in San Antonio. Dr. Waller completed his emergency medicine residency at Thomas Jefferson University in Philadelphia. He is board certified and fellowship trained in addiction medicine.

    Andrew J. Kolodny

    MD, FASAM

    Dr. Andrew Kolodny is the Co-Director of the Opioid Policy Research Colloborative at Brandeis University's Heller School.  His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics.

    Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national non profit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City. He has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including city-wide buprenorphine programs, naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.

    Mark A. Weiner

    MD, DFASAM

    Dr. Weiner received his undergraduate degree (B.S. Psychology) at the University of Michigan, Ann Arbor. He earned his medical degree at Cornell University Medical College in New York City. He completed his internship and residency in Internal Medicine at Northwestern University McGaw Medical Campus in Chicago, Illinois. He is Board Certified in Internal Medicine and Addiction Medicine. Since 2008, Dr. Weiner has worked at Pain Recovery Solutions in Ann Arbor, Michigan practicing full time Addiction Medicine and Pain Medicine. He is the Section Head of Addiction Medicine at Saint Joseph Mercy Hospital - Ann Arbor. He has participated in planning the ASAM preconfernece, Common Threads: Pain and Addiction, since 2011 and is the current vice chair. He also is a member of the ASAM Annual Meeting planning committee since 2014 and is an editor on the up-and-coming ASAM Pain and Addiction Handbook.

    Melvin I. Pohl

    MD, DFASAM

    Mel Pohl, MD, FASAM is a Board Certified Family Practitioner. He is the Medical Director of Las Vegas Recovery Center (LVRC). Dr. Pohl was a major force in developing LVRCs Chronic Pain Recovery Program. He is certified by the American Board of Addiction Medicine (ABAM), and a Fellow of the American Society of Addiction Medicine (ASAM). Dr. Pohl is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Nevada School of Medicine. He is a nationally known public speaker and co-author of Pain Recovery: How to Find Balance and Reduce Suffering from Chronic Pain (Central Recovery Press, 2009); Pain Recovery for Families: How to Find Balance When Someone Elses Chronic Pain Becomes Your Problem Too (Central Recovery Press, 2010). Dr. Pohl is the author of A Day without Pain (Central Recovery Press, 2008), which won a silver medal from Independent Publisher Book Award in May 2009. His new book writtten with Kathy Ketcham The Pain Antidote: The Proven Program to Help You Stop Suffering From Chronic Pain, Avoid Addiction to Painkillers - and Reclaim Your Life (DeCapo) will be out May 2015 . Las Vegas Recovery Center- Salary- Medical Director

  • Current Top Articles in Pain & Addiction (1 CME)

    Contains 3 Component(s), Medical Credits Offered

    This will be a brief survey of he top current articles in the realm of pain & addiction. By the conclusion of this presentation, attendees will: - Be able to describe the evidence against protracted and accelerated use of opioids in cases of non-cancer pain. - Enjoy a working knowledge of the CDC Guidelines AND the VA-DoD Guidelines that will provide direction in safely prescribing opioids. - Identify two major risk factors readily addressed in prevention of overdose deaths - Identify two assets in more safely managing patients requiring protracted opioid therapy.

    This will be a brief survey of he top current articles in the realm of pain & addiction. By the conclusion of this presentation, attendees will: - Be able to describe the evidence against protracted and accelerated use of opioids in cases of non-cancer pain. - Enjoy a working knowledge of the CDC Guidelines AND the VA-DoD Guidelines that will provide direction in safely prescribing opioids. - Identify two major risk factors readily addressed in prevention of overdose deaths - Identify two assets in more safely managing patients requiring protracted opioid therapy.

    William F. Haning, III

    MD, DFASAM, DFAPA

    Bill Haning is a tenured Professor of Psychiatry at the John A. Burns School of Medicine, University of Hawai’i, who serves as the Director of M.D. Programs for the medical school, Director of Addiction Psychiatry/Addiction Medicine Residency Training Programs and the Deputy for General Psychiatry, and Director for the medical students’ neurosciences curriculum (2nd year).  He is Principal Investigator for the Pacific Addiction Research Center (PARC®).  A Director of the American Society of Addiction Medicine (ASAM) and the Editor-in-Chief of the ASAM Weekly, he also serves as Chair of the Examination Committee for Addiction Psychiatry, American Board of Psychiatry and Neurology.  He received his A.B. (Philosophy) from Princeton University and M.D. from the University of Hawai`i at Manoa.  He is a Member of the American College of Psychiatrists, a Distinguished Fellow of the American Society of Addiction Medicine and a Distinguished Fellow of the American Psychiatric Association.

    Bill has been very fortunate.  He is certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine; has received teaching awards inclusive of the APA’s Nancy C.A. Roeske Certificate, the John M. Hardman Award for Mentorship from the John A. Burns School of Medicine of the University of Hawai`i, the Leonard Tow Humanism in Medicine Award, and the University of Hawai`i Regents’ Medal for Excellence in Teaching.    In 2014, the Hawai`i Medical Association designated him Hawai`i’s Physician of the Year.  The Force Surgeon (2001-2007) for both U.S. Marine Forces Pacific and for Marine Forces Central Command in Operation Iraqi Freedom, Bill served subsequently as the Division Psychiatrist, 4th Marine Division; his awards include the Legion of Merit.

  • A Legal Perspective (1 CME)

    Contains 3 Component(s), Medical Credits Offered

    Mark Seltzer will present legal issues that may impact you as the treating addictionologist / addiction psychiatrist / addiction psychologist / licensed healthcare professional and what steps you can take to protect yourself in view of those issues. Additionally, your patient may have a variety of legal issues for which you should be aware.

    Mark Seltzer will present legal issues that may impact you as the treating addictionologist / addiction psychiatrist / addiction psychologist / licensed healthcare professional and what steps you can take to protect yourself in view of those issues. Additionally, your patient may have a variety of legal issues for which you should be aware.

    Mark F. Seltzer

    JD

    In practice for more than 40 years, Mark F. Seltzer has earned a national reputation as a strong and capable advocate on behalf of physicians and professionals struggling with addictions and disabling conditions. He has appeared in numerous state and federal courts, and has successfully handled many claims and cases on behalf of disabled physicians and professionals across the country. His firm is a nationally recognized leader in the area of disability insurance law.

  • Group Discussion, Additional Resources, and Closing Remarks (1 CME)

    Contains 4 Component(s), Medical Credits Offered

    This session will help participants evaluate their current practice, while considering new recommendations/best practices to recognize strengths or gaps. This session also covers how to find and use apps, websites, or other resources to support practices or patients' treatment.

    This session will help participants evaluate their current practice, while considering new recommendations/best practices to recognize strengths or gaps. This session also covers how to find and use apps, websites, or other resources to support practices or patients' treatment. 

    Laura Morgan

    PharmD, MEd, BCPS

    Laura Morgan is currently Associate Professor in the Department of Pharmacotherapy and Outcomes Science at Virginia Commonwealth University/Medical College of Virginia. She works as a clinical pharmacist in the Supportive Care Clinic of Massey Cancer Center. She previously worked for 9 years in the Primary Care Pain Clinic in the MCV Physicians Internal Medicine clinic. She has co-authored publications related to using opioid risk screening tools and prescription monitoring programs in practice and unintentional prescription opioid overdose. 

    R. Corey Waller

    MD, MS, DFASAM

    R. Corey Waller, MD, MS, FACEP, DFASAM, is an addiction, pain and emergency medicine specialist. Dr. Waller earned his bachelor's degree in biology and his master's degree in neuromolecular biology at Southwest Texas State University in San Marcos, Texas. He earned his medical degree at University of Texas Medical School in San Antonio. Dr. Waller completed his emergency medicine residency at Thomas Jefferson University in Philadelphia. He is board certified and fellowship trained in addiction medicine.

This course is aimed toward healthcare providers, at any level, who see patients with chronic pain and substance use disorders. Provider specialties can include, but are not limited to: addiction medicine, pain medicine, emergency medicine, internal medicine, anesthesiology, and psychiatry. 

Upon completion, participants should be able to: 

  1. Identify and describe the new developments affecting the science, policy, and clinical practice of pain and addiction. 

  2. Analyze new research and science to develop practical applications for treatment or further research. 

  3. Evaluate their current practice, while considering new recommendations/best practices to recognize strengths or gaps. 

  4. Find and use apps, websites, or other resources to support their practice or their patient’s treatment. 

  5. Assess their feelings and attitudes towards the treatment of patients with pain and addiction. 

Accreditation Council for Continuing Medical Education (ACCME)

The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The ASAM Pain & Addiction: Common Threads Course XVIII

The American Society of Addiction Medicine designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification (Tmoc)

This course has been approved by the American Board of Addiction Medicine (ABAM).  Physicians enrolled in the ABAM Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 7.5 AMA PRA Category 1 Credit(s)™ for completing the The ASAM Pain & Addiction: Common Threads Course XVIII.

American Psychological Association (APA)

The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

CME Committee Members

  • Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair
  • Catherine Friedman, MD, FASAM, Vice-Chair
  • Noel Ilogu, MD, MRCP, FASAM
  • Herbert L. Malinoff, MD, FACP, DFASAM
  • Edwin A. Salsitz, MD, DFASAM
  • John C. Tanner, DO, CCFC, DFASAM

Staff - Sandy Metcalfe, Consultant, ASAM CME Committee, Professional Development Department

CME Committee, Program Planning Committee and Faculty Disclosure Information

In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ASAM Pain & Addiction Pre-Conference Course Faculty

Name

Disclosure

Andrea Barthwell, MD, DFASAM

Alere (not current); Apple Tree Life Sciences; Braeburn Pharmaceuticals (not current); Encounter Medical Group, P.C.; Ideal Option; The Manor (not current); Millennium Health (not current); Two Dreams; U.S. DOJ

Marla Golden, DO, FACEP

No Financial Relationships or Conflicts of Interest

William F. Haning, III, MD, DFASAM, DFAPA

No Financial Relationships or Conflicts of Interest

William S. Jacobs, MD

No Financial Relationships or Conflicts of Interest

Andrew J. Kolodny, MD, FASAM

No Financial Relationships or Conflicts of Interest

Laura Morgan, PharmD

No Financial Relationships or Conflicts of Interest

Mark Pew

No Financial Relationships or Conflicts of Interest

Melvin I. Pohl, MD, DFASAM

No Financial Relationships or Conflicts of Interest

Ilene Robeck MD, FASAM

No Financial Relationships or Conflicts of Interest

Mark Seltzer, JD

No Financial Relationships or Conflicts of Interest

Michael P. Sprintz, DO, FASAM

Cellarian Health, LLC Equity, CEO; Endo Pharmaceuticals, Honorarium, Chronic Pain Advisory Board Member

Corey Waller, MD, MS, DFASAM

No Financial Relationships or Conflicts of Interest

Alexander Walley, MD, FASAM

No Financial Relationships or Conflicts of Interest

Mark Weiner, MD, DFASAM

No Financial Relationships or Conflicts of Interest

 

ASAM Pain & Addiction Pre-Conference Course Planning Committee

 

Name

Disclosure

Mark Weiner, MD, DFASAM (Chair)

No Financial Relationships or Conflicts of Interest

Corey Waller, MD, MS, DFASAM

No Financial Relationships or Conflicts of Interest

William S. Jacobs, MD

No Financial Relationships or Conflicts of Interest

Laura Morgan, PharmD

No Financial Relationships or Conflicts of Interest

Melvin I. Pohl, MD, DFASAM

No Financial Relationships or Conflicts of Interest

Ilene Robeck MD, FASAM

No Financial Relationships or Conflicts of Interest

Michael P. Sprintz, DO, FASAM

Cellarian Health, LLC Equity, CEO; Endo Pharmaceuticals, Honorarium, Chronic Pain Advisory Board Member

Name

Disclosure

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

No Financial Relationships or Conflicts of Interest

Catherine Friedman, MD

No Financial Relationships or Conflicts of Interest

Noel Ilogu, MD, MRCP, DFASAM

No Financial Relationships or Conflicts of Interest

Herbert L. Malinoff, MD, FACP, DFASAM

No Financial Relationships or Conflicts of Interest

Edwin A. Salsitz, MD, DFASAM

No Financial Relationships or Conflicts of Interest

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior, Honorarium, Speaker; BDSI, Honorarium, Consultant/Speaker